BridgeMD
New treatment option for Mild Cognitive Impairment (MCI)
Official title Memory Support System for Older Chinese Americans With Mild Cognitive Impairment
ClinicalTrials.gov ID: NCT07142499
What this study is testing
- What it's testing
- The Memory Support System (MSS) from the Healthy Action to Benefit Independence \& Thinking® (HABIT) Program is an evidence-based, non-pharmacological intervention for mild cognitive impairment (MCI). Despite the clinical benefits and feasibility, the MSS was primarily developed and used with non-Hispanic White, English-speaking adults.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 55 and older
You may be able to join if
- self-identify as Chinese American;
- age 55 and above;
- a diagnosis of MCI as confirmed through documented clinical assessment and/or research-based diagnostic criteria;
- predominantly Cantonese- or Mandarin-speaking;
- able to read and write in Chinese;
You likely can't join if
- include:
- any significant neurologic disease that would impact their participation and completion of the trial;
- history of psychiatry disorder (DSM 5 criteria) within the last 12 months;
- history of reading or writing disability sufficient to interfere with MSS training; or
- concurrent participation in another relevant clinical trial.
See the full eligibility criteria
- self-identify as Chinese American;
- age 55 and above;
- a diagnosis of MCI as confirmed through documented clinical assessment and/or research-based diagnostic criteria;
- predominantly Cantonese- or Mandarin-speaking;
- able to read and write in Chinese;
- visual and auditory acuity adequate for cognitive testing;
- willing to complete the assessment measures;
- having someone in regular contact to serve as a study partner/informant;
- absence or stable use of prescribed memory-enhancing medications within the last 3 months.
- include:
- any significant neurologic disease that would impact their participation and completion of the trial;
- history of psychiatry disorder (DSM 5 criteria) within the last 12 months;
- history of reading or writing disability sufficient to interfere with MSS training; or
- concurrent participation in another relevant clinical trial.
The study team makes the final eligibility decision.
Where it's taking place
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 55 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New York, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.